10-K
Annual Report
Actuate Therapeutics, Inc.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
34 line items · 2 periods
XBRL
| Item | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 8,641,622 | 2,958,659 |
Other Non-Operating Current Assets | 566,278 | 36,907 |
Total current assets | 9,207,900 | 2,995,566 |
Other Non-Operating Non-Current Assets | 110,548 | 0 |
Total assets | 9,318,448 | 2,995,566 |
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Current liabilities: | ||
Accounts Payable | 1,921,189 | 3,421,840 |
Other Non-Operating Current Liabilities | 5,921,908 | 3,221,254 |
Other Current Liabilities | 888,449 | 277,500 |
Other Non-Operating Current Liabilities | 70,957 | 0 |
UIC License Agreement | 70,957 | — |
Total current liabilities | 8,802,503 | 6,920,594 |
Long term liabilities: | ||
Other Non-Operating Non-Current Liabilities | 0 | 988,049 |
Other Non-Operating Current Liabilities | 6,768 | 130,041 |
UIC License Agreement | 77,725 | 130,041 |
Other Non-Operating Current Liabilities | 404,991 | 404,991 |
Total long-term liabilities | 411,759 | 1,523,081 |
Total liabilities | 9,214,262 | 8,443,675 |
Temporary Equity | 0 | 94,178,404 |
Stockholders’ equity (deficit): | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 20 | 2 |
Total Stockholders' Equity | 132,484,015 | 5,468,006 |
Total Stockholders' Equity | (132,379,849) | (105,094,521) |
Total stockholders’ equity (deficit) | 104,186 | (99,626,513) |
Redeemable Convertible Preferred Stock | — | 94,178,404 |
Common Stock | 20 | 2 |
Additional Paid-in Capital | 132,484,015 | 5,468,006 |
Retained Earnings | (132,379,849) | (105,094,521) |
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) | 9,318,448 | 2,995,566 |